Harmony Biosciences Holdings (HRMY) Asset Utilization Ratio (2020 - 2026)

Harmony Biosciences Holdings has disclosed Asset Utilization Ratio across 7 years of filings, most recently posting 0.71 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.71, down 2.48% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.71 (down 2.48% YoY), and the FY2025 annual result was 0.76, down 3.12% from the prior year.
• Asset Utilization Ratio came in at 0.71 for Q1 2026 at Harmony Biosciences Holdings, up from 0.7 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.77 in Q2 2024 to a low of 0.66 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.71 (2025), against an average of 0.72.
• Peak annual rise in Asset Utilization Ratio reached 41.28% in 2022, while the deepest fall reached 10.27% in 2022.
• Harmony Biosciences Holdings' Asset Utilization Ratio stood at 0.66 in 2022, then grew by 10.19% to 0.73 in 2023, then grew by 1.26% to 0.74 in 2024, then dropped by 5.56% to 0.7 in 2025, then increased by 0.94% to 0.71 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.71 (Q1 2026), 0.7 (Q4 2025), and 0.71 (Q3 2025), per Business Quant data.